G. Migliori (Varese (VA), Italy), S. Borisov (Moscow, Russian Federation)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Multidrug-resistant tuberculosis in children of Belarus
L. Gorbach (Minsk, Belarus)
|   |
TB Portals Program in Ukraine
D. Butov (Kharkiv, Ukraine), A. Gabrielian (Bethesda, MD, United States of America), V. Myasoedov (Kharkiv, Ukraine), T. Butova (Merefa, Ukraine), A. Long (Bethesda, MD, United States of America), E. Matlock (Bethesda, MD, United States of America), D. Hurt (Bethesda, MD, United States of America), A. Grinev (Bethesda, MD, United States of America), A. Rosenthal (Bethesda, MD, United States of America)
| |
Morphological changes of a small intestine wall in patients with multidrug resistant tuberculosis
O. Pidverbetska (Chernivtsi, Ukraine), L. Todoriko (Chernivtsi, Ukraine)
| |
Treatment of multidrug-resistant tuberculosis in Uzbekistan from 2012 to 2018: does practice follow policy?
R. Usmanova (Tashkent, Uzbekistan), N. Parpieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan), H. Davtyan (Nor Hachn, Ukraine), O. Danisiuk (Kyiv, Ukraine), A. Kumar (Paris, France), J. Gadoev (Tashkent, Uzbekistan), S. Alaverdyan (Bielefeld, Germany), K. Dumchev (Kyiv, Ukraine), B. Abdusamatova (Tashkent, Uzbekistan), I. Butabekov (Tashkent, Uzbekistan)
| |
Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India.
Y. Jagdhari (Lucknow, India), A. Verma (Lucknow, India), S. Kant (Lucknow, India), R. Mishra (Lucknow, India), K. Srivastava (Lucknow, India), . Bajpai (Lucknow, India)
| |
Efficiency of intravenous treatment with levofloxacin in patients with MDR pulmonary tuberculosis in the intensive phase of chemotherapy
D. Butov (Kharkiv, Ukraine), M. Kuzhko (Kiev, Ukraine), M. Gumeniuk (Kiev, Ukraine), O. Denysov (Kiev, Ukraine), T. Butova (Merefa, Ukraine)
| |
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
N. Eremeeva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), T. Umpeleva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), D. Vakhrusheva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), S. Skornyakov (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), L. Lavrenchuk (Ekaterinburg (Sverdlovsk Oblast), Russian Federation)
| |
The effects of bedaquiline and fluoroquinolone-based treatment regimens in patients with MDR/XDR-TB on QT prolongation
E. Zhukova (Novosibirsk, Russian Federation), Y. Batyrshina (Novosibirsk, Russian Federation)
| |
Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis
E. Vaniev (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), N. Kuzmina (Surgut, Russian Federation), A. Samoilova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB
E. Kildusheva (Ekaterinburg, Russian Federation), I. Medvinsiy (Ekaterinburg, Russian Federation), S. Skornyakov (Ekaterinburg, Russian Federation), T. Lugovkina (Ekaterinburg, Russian Federation), T. Umpeleva (Ekaterinburg, Russian Federation), N. Eremeeva (Ekaterinburg, Russian Federation)
| |
Risk factors for radiological and functional sequelae in multi-drug resistant tuberculosis
M. Ferchichi (Ariana, Tunisia), S. Ben Saad (Ariana, Tunisia), A. Ben Mansour (Ariana, Tunisia), O. Neffati (Ariana, Tunisia), S. Belhadj (Ariana, Tunisia), L. Slim (Ariana, Tunisia), H. Daghfous (Ariana, Tunisia), F. Tritar (Ariana, Tunisia)
| |
Efficacy of linezolide-free chemotherapy schemes in patients with highly drug-resistant tuberculosis
O. Otpuschennikova (Moskow, Russian Federation), T. Morozova (Saratov, Russian Federation), N. Doktorova (Moskow, Russian Federation)
| |
Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020
R. Usmanova (Tashkent, Uzbekistan), N. Parpieva (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan), H. Davtyan (Nor Hachn, Armenia), S. Alaverdyan (Bielefeld, Germany), J. Gadoev (Tashkent, Uzbekistan)
| |
Tolerance to chemotherapy regimens with bedaquiline in adolescents with MDR/XDR pulmonary TB
O. Piskunova (Moscow, Russian Federation), L. Panova (Moscow, Russian Federation), E. Ovsyankina (Moscow, Russian Federation), E. Krushinskaya (Moscow, Russian Federation)
| |
LTBI - MDR/XDR-TB cases - should all be treated?
R. Pereira De Matos Cordeiro (Torres Vedras, Portugal), M. Cavaco (Torres Vedras, Portugal), C. Silvestre (Torres Vedras, Portugal), A. Nunes (Torres Vedras, Portugal), J. Araújo (Torres Vedras, Portugal), P. Raimundo (Torres Vedras, Portugal), D. Duarte (Torres Vedras, Portugal), C. Cardoso (Torres Vedras, Portugal), N. André (Torres Vedras, Portugal), R. Macedo (Lisbon, Portugal), A. Domingos (Torres Vedras, Portugal)
| |
Effectiveness of complex treatment of bilateral destructive pulmonary XDR-tuberculosis
A. Tikhonov (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
MDR-TB- A THREE YEAR RURAL TERTIARY CARE HOSPITAL EXPERIENCE
P. Chatterjee (Gurgaon (Haryana), India), V. Goyal (Gurgaon (Haryana), India), K. Sharma (Gurgaon (Haryana), India), S. Hasija (Gurgaon (Haryana), India)
| |
Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
O. Karaman (Izmir, Turkey), Y. Varol (Izmir, Turkey), C. Bicmen (Izmir, Turkey), T. Akarca (Izmir, Turkey), S. Dereli (Izmir, Turkey), D. Ozbakir (Izmir, Turkey)
| |
Moxifloxacin, as an alternative in the treatment of patients with the newly diagnosed pulmonary TB with monoresistance to pirazinamid, or its intolerance
T. Butova (Merefa, Ukraine), M. Kuzhko (Kiev, Ukraine), M. Gumeniuk (Kiev, Ukraine), T. Sprynsian (Kiev, Ukraine), L. Grechanyk (Kiev, Ukraine), D. Butov (Kharkiv, Ukraine)
| |